Source disclosure: February 20, 2026
Chiome Bioscience Inc. [4583.T]
TOKYO, Feb 20 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the large exercise of its 23rd warrant shares (exercise price adjustment clause attached) from February 1 to February 19, 2026.
During this period, a total of 1,436,200 shares were exercised out of 14,362 warrants issued, representing an exercise ratio of 10.56%. As of the end of January, there were 122,100 warrants remaining unexercised, equivalent to 12,210,000 shares. By the end of February, the number of unexercised warrants decreased to 107,738, corresponding to 10,773,800 shares. Detailed exercise activities during the month included: - On February 2, 36,200 shares were delivered against the exercise of warrants at an exercise price of ¥103.10 per share.
- On February 4, 100,000 shares were transferred after exercising warrants at ¥104 per share. - On February 9, 300,000 shares were delivered following the exercise of warrants at ¥104 per share. - On February 19, 600,000 shares were transferred upon exercising warrants at ¥105.80 per share. At the end of January, the outstanding ordinary shares stood at 69,453,800 shares, including self-held shares amounting to 12,149 shares.
AI-translated content. 🟢 Confidence: High See terms • Original filing